0023-6498 : Ubrelvy 50 mg Oral Tablet


NDC0023-6498
Labeler: Allergan, Inc.
Product Type: Human Prescription Drug
Drug Name:  Ubrelvy
Dosage Form: Oral Tablet
Application #: NDA211765
Rev. Date: 


Appearance:


Markings: U;50
Shapes:  Capsule
Colors:  White
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0023-6498-01: 1 PACKET IN 1 BOX (0023‑6498‑01) / 1 TABLET IN 1 PACKET
  • 0023-6498-02: 1 TABLET IN 1 PACKET (0023‑6498‑02)
  • 0023-6498-04: 4 PACKET IN 1 BOX (0023‑6498‑04) / 1 TABLET IN 1 PACKET
  • 0023-6498-06: 6 PACKET IN 1 BOX (0023‑6498‑06) > 1 TABLET IN 1 PACKET
  • 0023-6498-08: 8 PACKET IN 1 BOX (0023‑6498‑08) > 1 TABLET IN 1 PACKET
  • 0023-6498-10: 10 PACKET IN 1 BOX (0023‑6498‑10) > 1 TABLET IN 1 PACKET
  • 0023-6498-12: 12 PACKET IN 1 BOX (0023‑6498‑12) > 1 TABLET IN 1 PACKET
  • 0023-6498-16: 16 PACKET IN 1 BOX (0023‑6498‑16) > 1 TABLET IN 1 PACKET
  • 0023-6498-30: 30 PACKET IN 1 BOX (0023‑6498‑30) > 1 TABLET IN 1 PACKET

Active Ingredients:

  • Ubrogepant

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Tocophersolan
  • Mannitol
  • Microcrystalline Cellulose
  • Sodium Chloride
  • Croscarmellose Sodium
  • Sodium Stearyl Fumarate /

Pharmaceutical Classes:

  • Calcitonin Gene-related Peptide Receptor Antagonist [EPC]
  • Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0023-6501 Ubrelvy 100 mg Oral Tablet by Allergan, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0023-6498 QR Code

< Prev: 0023-6465Next: 0023-6501 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.